A model of the competitive radioimmunoassay standard curve, based on the Law of Mass Action, has been developed and used in conjunction with expenmental and counting errors to predict the assay detection limit and precision profiles. We verified the model with hapten radioimmunoassays performed in our laboratory. The resulting computer program can be used to determine the optimum antiserum concentration-depending on its affinity-and labeled-antigen concentration-according to its specific activity and nonspecific binding. The graphical representation of this model provides radioimmunologists with a practical tool for assay optimization.
mathematical analyses used are often too complicated to be readily applied to a specific radioimmunoassay, and there is no way of clearly showing the dependenceof the detection limit on assay characteristic8 such as reagent properties and the amount of nonspecific binding. Finally, there is no way of optimizing the system to evaluate the precision limit, i.e., the concentration of unlabeled antigen for which the precision of the assay is sufficient and satisfactory. We have therefore developed a graphical representation of the changes in the detection or precision limits as a function of the following assay variables: specific activity, antibody affinity constant, and nonspecific binding of labeled antigen. This graphical representation may be used for most radioimniunoassays. We first developed a model of the standard curve, based on the Law of Mass Action, and then estimated the variations in the response attributable to experimental and counting errors.
MaterIals and Methods

Theory
The mathematical representation of the antigenantibody interaction assumes that the antigen and antibody are homogeneous, that their interaction can be described with a single equilibrium constant, that the labeled and unlabeled antigen possessidentical binding In the presence of a concentration C of unlabeled antigen, the bound-to-total ratio of labeled antigen becomesb0 multiplied by b. Therefore 1-propanol, and bound and free PAF were separated by filtration through GF/C glass ifiters (Whatman Scientific Ltd., Maidatone, U.K.).
Counting efficiencies
were 80% for the gamma counter (NE 1600 Nuclear Enterprises Ltd., Edinburgh, Scotland) and 56% for the a-counter (Rackbeta 1214; LKB Wallac, Turku, Finland).
Results
Three features of the mathematical model were checked experimentally: prediction of the standard curve (Figure 2) , determination of the precision proffle (Figure 3) , and the changes in the detection limit with changing reagent concentrations (Figure 4) . Figure 5 shows the values for initial binding and labeled-antigen concentration giving the best detection and precision limits for various affinity constants and specific activities of unlabeled antigen. The profiles for the detection and precision limits are parallel, but have different optima; the use of the precision profile as the only parameter for assay design implies working with more bound antigen. These relationships are extended in Figure 6 , which shows the optimal conditions for increasing the detection limit with tracers of different specific activities.
In every case, working with high-affinity antibody requires that the amount of labeled antigen added be decreased. On the other hand, when the affinity constant is <1010 L/mol, it is better to increase the amount of tracer, to reduce random counting errors. Figure 7 shows how a deviation from optimal conditions may affect the assay detection limit. counts/mm),and the antibodywas dilutedto obtain different values for b0
limit that is, theoretically, sixfold lower than that obtained with tritiated tracers.
NSB may decrease the assay detection limit, especially when high-activity labels and low-affinity antibodies are used (Table 1) . However, the optimal initial binding or tracer concentration for a specific radioimmunoassay doesnot vary substantially when the NSB is <10% (data not shown).
DIscussion
In this simple method for obtaining maximal radioimmunoassay sensitivity, the response variation for the standard curve is estimated from experimental errors in the counting of the bound fractions. Our model takes into consideration realistic values for experimental errors commonly encountered in current radioimmunoas- 
>30-50%
if a labeled antigen of high specificactivity is used; a deviation from the optimal conditions may decrease the assay performance.
The optimal conditions for radioimmunoassays designed according to the precision profile are different from those based on the detection limit proffle. If the precision limit is used as the criterion for the assay, then more bound antigen must be used, but the assay performance will be reduced.
The results also show that the amount of NSB affects the detection limit. Therefore, reducing this may improve assay quality, especially when labels of high SA Cl,nmol.
SA Clftnmol with reagentquality: effect of the specific actMty of the tracer(1500 kCl/mol, #{149}; 50 kCl/mol, 0) andantibody affinity(K)
The dashedlinerepresents the detection limit for a tracer of infinitespecific activity specific activity are used. The data emphasize the advantages of using iodinated tracers, especially when the antibody affinity is Antibodyaffinity,L/mol. high. However, for antibody affinities <lOlO L/mol, replacing iodinated tracers with labels of potentially higher specific activity, e.g., enzymic or fluorescent compounds, will provide advantages of safety or practicability rather than increased sensitivity. This does not hold for immunometric assays, in which the detectability of the label per se and the reduction of counting errors are much more important factors in improving the detection limit (9).
In conclusion, we have developed a method of assessing antigen-antibody interaction based on realistic assumptions. This approach offers a simple and rational way of optimizing radioimmunoassay performance.
